Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

IBBIBB
Showing 7 of 20 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in ISHARES BIOTECHNOLOGY ETF

Qube Research & Technologies Ltd holds 47,278 shares of IBB (ISHARES BIOTECHNOLOGY ETF), worth $9M as of 2026-Q2. The position was increased (+575.7% shares). IBB represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$9M

Current Shares

47,278

Total Value Change

+$9M

Total Shares Change

+47,278

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
47,278
+575.7%
$9M0.0%$190.19
44
2026-Q1
Increased
6,997
+500.1%
$1.2M0.0%$170.10
41
2025-Q4
Decreased
1,166
-86.4%
$196,7860.0%$168.89
0
2025-Q3
Increased
8,571
+235.8%
$1.2M0.0%$142.26
41
2025-Q2
Increased
2,552
+159x
$322,8540.0%$126.26
38
2025-Q1
New
16
-
$2,0460.0%$130.07
17
2024-Q3
Exited
0
-100.0%
$00.0%$144.46
0

Other major holders of IBB: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used